RXRX Recursion Pharmaceuticals In

held by 1 manager in Q2 2023

Manager	% of their portfolio	Held	Activity	Value	Shares
Stanley Druckenmiller Duquesne Family Office	0.36%	2.0 yr	—	$10M	1,385,950

Search